Edwards Lifesciences CorpEWBalance sheet

Market cap
$49.9B
P/E ratio
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
Cash and cash equivalents 3961713114206547189308187141,1791,2008677731,1483,059
Marketable securities, current ----785506341519242338219604446501931
Total cash & short-term investments3961713114201,4391,2251,2711,3389571,5171,4201,4711,2191,6493,990
Accounts receivable, net277284321303288315366422457544515582643775609
Inventories2042612813092973403975556076418027278761,1681,087
Total current assets1,0331,1691,2921,7262,2952,0482,2402,5322,2872,9843,0913,1813,0964,0366,285
Property, plant and equipment, net2703043734224434835806808681,0601,3951,5471,6331,7491,686
Marketable securities, non-current 252221222413805325675065868021,8341,239584308
Total non-current assets7358129309991,2302,0112,2703,1643,0373,5044,1465,3225,1975,3286,770
Total assets 1,7671,9812,2222,7253,5244,0594,5105,6965,3246,4887,2378,5038,2939,36313,055
Accounts payable48857548586497117134180197205202201197
Long-term debt, current -------598-------
Total current liabilities3383353473464344765331,4038779028941,0321,0221,1951,505
Long-term debt, non-current ---593598600822438594594595596596597598
Total non-current liabilities-----------1,6341,4631,4481,487
Total liabilities -----------2,6672,4862,6442,992
Common stock and paid-in capital 328120124126129239243212215218636642646651655
Retained earnings1,1241,3611,6542,0462,8423,3373,9061,9622,6953,7424,5656,0687,5908,99213,167
Stockholders' equity1,3081,3381,4791,5592,1912,5032,6192,9563,1404,1484,5745,8365,8076,71910,063
Total debt---5935985978221,036594594595596596597598
Net debt---173-841-628-449-301-363-922-825-876-623-1,051-3,392
D/E ratio (%)---3827.323.831.435.118.914.31310.210.38.95.9
Working capital